AI Article Synopsis

  • The implantation of electrodes for cardiac devices demands a high level of technical skill and precision, particularly in the right ventricle and atrium, impacting patient safety and therapy effectiveness.
  • Focus is placed on the differences between apical and septal stimulation when positioning electrodes in the ventricle.
  • The article serves as a practical guide for implanters, detailing the steps for proper electrode placement, but does not cover techniques for physiological stimulation like cardiac resynchronization therapy (CRT) or conduction system pacing (CSP).

Article Abstract

The implantation of electrodes for cardiac implantable electronic devices (CIED) requires profound technical understanding and precise execution. The positioning of electrodes in the right ventricle and atrium has significant implications for patient safety and the effectiveness of CIED therapy. Particular focus is given to the distinction between apical and septal stimulation in ventricular positioning. Based on current data, this article provides a practice-oriented guide that leads implanters through the individual steps of electrode positioning. The implantation of electrodes for physiological stimulation (cardiac resynchronization therapy, CRT, and conduction system pacing, CSP) is not addressed in this article.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11161426PMC
http://dx.doi.org/10.1007/s00399-024-01019-9DOI Listing

Publication Analysis

Top Keywords

cardiac implantable
8
implantable electronic
8
implantation electrodes
8
[lead placement
4
placement cardiac
4
electronic devices]
4
devices] implantation
4
electrodes cardiac
4
electronic devices
4
devices cied
4

Similar Publications

Aims: Evidence regarding the safety of early discharge following transcatheter aortic valve implantation (TAVI) is limited. The aim of this study was to evaluate the safety of very early (<24) and early discharge (24-48 h) as compared to standard discharge (>48 h), supported by the implementation of a voice-based virtual assistant using artificial intelligence (AI) and natural language processing.

Methods And Results: Single-arm prospective observational study that included consecutive patients who underwent TAVI in a tertiary hospital in 2023 and were discharged under an AI follow-up programme.

View Article and Find Full Text PDF

Introduction: Although left ventricular assist device (LVAD) implantation is associated with improved survival in patients with end-stage heart failure, the impact of preoperative pulmonary function on short-term outcomes is unclear.

Methods: We conducted a retrospective review of all primary LVAD implants at a single institution. Common measures of preoperative pulmonary function were evaluated.

View Article and Find Full Text PDF

Objective: The objective of this study was to improve long-term postoperative survival in a porcine cardiac valve surgery model by utilizing cardiopulmonary bypass (CPB) via left thoracotomy. The study aimed to share refined techniques and insights accumulated over years at a single-center animal clinical trial facility.

Method: A total of 196 Chinese Large White pigs weighing between 60 and 75 kg were used in the study.

View Article and Find Full Text PDF

Titin truncating variants (TTNtv) are the main genetic cause of dilated cardiomyopathies (DCMs). The phenotype and prognosis of probands have been evaluated in several large cohorts. However, few data are available on intrafamilial expressivity.

View Article and Find Full Text PDF

[Role of ventricular tachycardia ablation in patients with systolic heart failure].

Herzschrittmacherther Elektrophysiol

January 2025

Sektion Rhythmologie, Klinik für Innere Medizin und Kardiologie, Herzzentrum Dresden, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 76, 01307, Dresden, Deutschland.

Patients with systolic heart failure (HF) and structural heart disease often suffer from ventricular tachycardias (VTs), which lead to increased morbidity and mortality. Despite advancements in pharmacological therapy and the use of implantable cardioverter-defibrillators, treatment options are limited due to side effects and decreased effectiveness. Catheter ablation (CA) has emerged as a promising therapy for drug-refractory VTs, especially in patients with structural heart disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!